{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Ketorolac+LS", "query": { "intervention": "Ketorolac LS" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 13, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Ketorolac+LS&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-07T23:27:14.888Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00377546", "title": "Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Vitrectomy" ], "interventions": [ { "name": "Nepafenac", "type": "DRUG" }, { "name": "Ketorolac LS, Bromfenac", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Innovative Medical", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2008-09-25", "last_synced_at": "2026-09-07T23:27:14.888Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00377546" }, { "nct_id": "NCT00366691", "title": "Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cataract Extraction" ], "interventions": [ { "name": "Acular LS", "type": "DRUG" }, { "name": "Lotemax", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Medical University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2006-02", "completion_date": "2007-09", "has_results": false, "last_update_posted_date": "2018-06-14", "last_synced_at": "2026-09-07T23:27:14.888Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00366691" }, { "nct_id": "NCT00348244", "title": "Ketorolac vs. Steroid in the Prevention of CME", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cataract" ], "interventions": [ { "name": "Ketorolac, Prednisolone Acetate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Innovative Medical", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2007-01-17", "last_synced_at": "2026-09-07T23:27:14.888Z", "location_count": 1, "location_summary": "Stony Brook, New York", "locations": [ { "city": "Stony Brook", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00348244" }, { "nct_id": "NCT00330798", "title": "A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Photorefractive Keratectomy" ], "interventions": [ { "name": "nepafenac 0.1%", "type": "DRUG" }, { "name": "ketorolac 0.4%", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 40, "start_date": "2006-02", "completion_date": "2006-06", "has_results": false, "last_update_posted_date": "2016-11-18", "last_synced_at": "2026-09-07T23:27:14.888Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00330798" }, { "nct_id": "NCT00407017", "title": "Therapeutic Variables in Cataract Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cataract Surgery" ], "interventions": [ { "name": "Gatifloxacin", "type": "DRUG" }, { "name": "Ketorolac LS", "type": "DRUG" }, { "name": "Pred Forte", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Nepafenac", "type": "DRUG" }, { "name": "EconoPred Plus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Innovative Medical", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2007-08-21", "last_synced_at": "2026-09-07T23:27:14.888Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00407017" }, { "nct_id": "NCT00791323", "title": "Efficacy of Ketorolac 0.4% in Prostaglandin Suppression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Inflammation" ], "interventions": [ { "name": "Ketorolac 0.4%", "type": "DRUG" }, { "name": "Lubricating Eye Drop", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 9, "start_date": "2008-11", "completion_date": "2009-08", "has_results": true, "last_update_posted_date": "2011-09-23", "last_synced_at": "2026-09-07T23:27:14.888Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00791323" }, { "nct_id": "NCT00576329", "title": "Topical 0.4% Ketorolac and Vitreoretinal Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Surgery" ], "interventions": [ { "name": "Ketorolac", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 76, "start_date": "2006-11", "completion_date": "2007-10", "has_results": false, "last_update_posted_date": "2014-05-14", "last_synced_at": "2026-09-07T23:27:14.888Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00576329" }, { "nct_id": "NCT00332774", "title": "Nevanac 3-Month Safety Study With QID Dosing", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cataract" ], "interventions": [ { "name": "Nepafenac ophthalmic solution 0.1%", "type": "DRUG" }, { "name": "Ketorolac Tromethamine ophthalmic solution 0.4%", "type": "DRUG" }, { "name": "Nepafenac ophthalmic suspension vehicle", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": null, "sex": "ALL", "summary": "10 Years and older" }, "enrollment_count": 149, "start_date": "2006-02", "completion_date": "2006-12", "has_results": false, "last_update_posted_date": "2012-03-05", "last_synced_at": "2026-09-07T23:27:14.888Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00332774" }, { "nct_id": "NCT00348582", "title": "Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cataract" ], "interventions": [ { "name": "Ketorolac, Nepafenac", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Innovative Medical", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2007-06-25", "last_synced_at": "2026-09-07T23:27:14.888Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00348582" }, { "nct_id": "NCT00478036", "title": "Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Open Angle Glaucoma" ], "interventions": [ { "name": "Acular LS", "type": "DRUG" }, { "name": "Pred Forte", "type": "DRUG" }, { "name": "Refresh Tears", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 31, "start_date": "2007-05", "completion_date": "2014-01", "has_results": true, "last_update_posted_date": "2016-10-07", "last_synced_at": "2026-09-07T23:27:14.888Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00478036" } ] }